AzTrials
AzTrials

Social PhobiaSOFIE-8NCT01312571

Treatment of Social Phobia Over the Internet

A study testing Internet-based cognitive behavioural therapy (iCBT) and Internet-based computerized attention training in people with Social Phobia, run by Umeå University at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Forty-eight people diagnosed with social phobia in an experimental study that randomized into two treatment groups: 1) Internet-based Cognitive Behavioural Therapy (iCBT) (n = 24) or 2) computerized attention training (n = 24). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Social Phobia
What is being tested?
Internet-based cognitive behavioural therapy (iCBT) and Internet-based computerized attention training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteSweden
Study dates
Aug 2010to Feb 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants must meet criteria for social phobia using the International classification system Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV).

Who cannot join

  • Individuals with current depression and/or is suicide prone will be excluded from the study.
  • With fMRI the following criteria must not be filled: previous surgery in the heart or brain, metals implanted in the body, dental braces or bridge; piercings that can´t be taken out, tattoos (shoulders, arms and back is not so good, the legs are okay if it is not too large); trouble to lie still for about an hour, pregnancy or history of neurological diseases.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Department of Psychology, Umeå University

    Umeå, Västerbotten County, 901 87

Other trials in Sweden

About this study

Official title: Functional Magnetic Resonance Imaging (fMRI) and Treatment of Social Phobia Over the Internet: Cognitive Behavioural Therapy (CBT) Versus Computerized Attention Training and the Possible Effect of Genetic Variation. (SOFIE-8)

Forty-eight people diagnosed with social phobia in an experimental study that randomized into two treatment groups: 1) Internet-based Cognitive Behavioural Therapy (iCBT) (n = 24) or 2) computerized attention training (n = 24). After nine weeks we change the condition of the two groups of research participants, which should therefore be given both treatments. Pre-and post measurement of functional magnetic resonance imaging (fMRI) will take place in the first round of treatment. Genotyping based on saliva samples takes place before the start of treatment, at the first fMRI measurement, for those who voluntarily leave the sample.

Study hypothesis

Read more

How is the brain activity of emotional processing and anxiety affected after completing an Internet-based CBT compared with computerized attention training? Does the treatment response of an Internet based treatment affects by variations in serotonin-transporter-linked promoter region (5-HTTLPR) and tryptophan hydroxylase-3 (TPH3) genes?

How is the genetic variations related to symptoms in social phobia (pre treatment)?

Conditions
Social Phobia
Being tested
Internet-based cognitive behavioural therapy (iCBT), Internet-based computerized attention training
Medical subject headings
Phobia, Social

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet-based cognitive behavioural therapy (iCBT)Behavioural

    The Internet-based cognitive behavioural therapy (iCBT) consists of our structured self-help program lasting a total of nine active treatment weeks. This treatment program has been well evaluated and involved in several research projects.

  • Internet-based computerized attention trainingBehavioural

    The Internet-based computerized attention training program lasting a total of four active treatment weeks. The treatment is consist of two training sessions per week, about 10 minutes long.

Study groups in NCT01312571
Study groupRoleWhat they receive
Cognitive behavior therapy via the internetActive comparatorCognitive behavior therapy via the internet with therapist support.
Receives: Behavioral: Internet-based cognitive behavioural therapy (iCBT)
Attentional retrainingActive comparatorAttentional retraining as described by Nader Amir.
Receives: Behavioral: Internet-based computerized attention training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in recruited brain regions measured using regional cerebral blood flow

    Blood-oxygen-level dependence (BOLD) signal change as measured with 3.0 T fMRI

    Change from baseline in BOLD signal expected between time frames.

    Measured: pretreatment (week 0), post treatment (week 11), 1 yr follow-up (week 63)

  2. Social Phobia Screening Questionnaire (SPSQ)

    Social Phobia Screening Questionnaire (SPSQ), diagnostic tool for social phobia.

    Change from baseline in social anxiety symptoms expected between time frames.

    Measured: pretreatment (week 0), post treatment (week 11), 1 yr follow-up (week 63)

  3. Liebowitz Social Anxiety Scale self rated version (LSAS-SR)

    Measure social anxiety and social phobia.

    Change from baseline in social anxiety symptoms expected between time frames.

    Measured: pretreatment (week 0), post treatment (week 11), 1 yr follow-up (week 63)

  4. Social Interaction Anxiety Scale (SIAS)

    Measure social anxiety and social phobia.

    Change from baseline in social anxiety symptoms expected between time frames.

    Measured: pretreatment (week 0), post treatment (week 11), 1 yr follow-up (week 63)

  5. Social Phobia Scale (SPS)

    Measure social phobia.

    Change from baseline in social anxiety symptoms expected between time frames.

    Measured: pretreatment (week 0), post treatment (week 11), 1 yr follow-up (week 63)

Secondary outcomes (4)
  1. Variation in genes that have been associated with emotional processing

    We will study allelic variation in genes that have been associated with emotional processing e.g. monoaminergic gene polymorphisms such as the serotonin-transporter-linked promoter region (5-HTTLPR), tryptophan hydroxylase-2 (TPH2) G-703T, and Catechol-O-methyltransferase (COMT) 158Val/Met polymorphism

    Measured: pretreatment (week 0).

  2. Montgomery Åsberg Depression Rating Scale (MADRS-S)

    Measure depression.

    Change from baseline in depressive symptoms expected between time frames.

    Measured: pretreatment (week 0), post treatment (week 11), 1 yr follow-up (week 63)

  3. Beck Anxiety Inventory (BAI)

    Measure anxiety.

    Change from baseline in anxiety symptoms expected between time frames.

    Measured: pretreatment (week 0), post treatment (week 11), 1 yr follow-up (week 63)

  4. Quality of Life Inventory (QOLI)

    Measure quality of life.

    Change from baseline in quality of life expected between time frames.

    Measured: pretreatment (week 0), post treatment (week 11), 1 yr follow-up (week 63)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2011 (estimated)
  2. Study startAug 2010
  3. Primary completionFeb 2016
  4. Study completionFeb 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01312571
Sponsor's protocol ID
2010-185-31 M
Acronym
SOFIE-8
Status last verified
Oct 2016
First submitted
31 Aug 2010
Last updated
1 Nov 2016
Results posted
No
Data monitoring committee
Yes

Publications

  • Mansson KN, Frick A, Boraxbekk CJ, Marquand AF, Williams SC, Carlbring P, Andersson G, Furmark T. Predicting long-term outcome of Internet-delivered cognitive behavior therapy for social anxiety disorder using fMRI and support vector machine learning. Transl Psychiatry. 2015 Mar 17;5(3):e530. doi: 10.1038/tp.2015.22.

    PubMed 25781229
  • Mansson KN, Salami A, Frick A, Carlbring P, Andersson G, Furmark T, Boraxbekk CJ. Neuroplasticity in response to cognitive behavior therapy for social anxiety disorder. Transl Psychiatry. 2016 Feb 2;6(2):e727. doi: 10.1038/tp.2015.218.

    PubMed 26836415
  • Mansson KN, Carlbring P, Frick A, Engman J, Olsson CJ, Bodlund O, Furmark T, Andersson G. Altered neural correlates of affective processing after internet-delivered cognitive behavior therapy for social anxiety disorder. Psychiatry Res. 2013 Dec 30;214(3):229-37. doi: 10.1016/j.pscychresns.2013.08.012. Epub 2013 Sep 21.

    PubMed 24064198

Questions about this trial

What is this clinical trial studying?

A study testing Internet-based cognitive behavioural therapy (iCBT) and Internet-based computerized attention training in people with Social Phobia, run by Umeå University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in recruited brain regions measured using regional cerebral blood flow (time frame: pretreatment (week 0), post treatment (week 11), 1 yr follow-up (week 63)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01312571, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in